News Imexpharm Corporation

Equities

IMP

VN000000IMP0

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
81,600 ^VND	+4.35%		+19.68%	+58.59%

Jul. 04	Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024	CI
May. 27	Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024	Jul. 04	CI
Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	May. 27	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors	Dec. 19	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-18	CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023	23-09-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-18	CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors	23-05-04	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd.	22-08-24	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-18	CI
Imexpharm Corporation Announces Personnel Change	22-05-30	CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022	22-05-13	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Imexpharm Corporation

Equities

IMP

VN000000IMP0

Summary

Filters